Indunil Karunarathna: Kawasaki Disease at the Intersection of Immunology, Cardiology, and Vascular Biology
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Kawasaki disease is a unique pediatric inflammatory disorder that occupies a critical intersection between immunology, cardiology, and vascular biology.
Although classically described as an acute, self-limited febrile illness of childhood, it is now understood to be a complex immune-mediated vasculitis with the potential for lifelong cardiovascular consequences.
The disease process is driven by dysregulated innate and adaptive immune responses that target the vascular endothelium, particularly within the coronary arteries, leading to aneurysm formation, thrombosis, and long-term vascular remodeling.
Early diagnosis and timely immunomodulatory therapy, especially intravenous immunoglobulin, dramatically reduce morbidity and mortality, transforming outcomes from historically fatal to largely survivable.
However, survival does not equate to cure.
Even in patients whose coronary aneurysms regress, persistent endothelial dysfunction and vascular scarring confer long-term cardiovascular risk.
Kawasaki disease should therefore not be conceptualized as a transient pediatric illness, but rather as a lifelong cardiovascular condition originating in childhood, requiring structured acute management, long-term surveillance, and transitional care into adulthood.”
Title: Kawasaki Disease: An Immune-Mediated Vasculopathy with Lifelong Cardiovascular Consequences
Authors: Indunil Karunarathna, Prasan Gunasena, Kap Gunawardana, Sam Rajapaksha, Palith Aluthge, Asok Jayawardana, Cam Fernando, USG Vidanagama, UPN Ekanayake, TMB Hapuarachchi, Sach Senanayaka, Ban Rathnayak, AN Thilak Warnakulasooriya, Palinda Athulgama, Mud Abeyek, San Dius, Ram Ranwala, Sanj Godage, Suni Senadeera, Jaga Wijepala, Neha Perera, Sena Gunathilake, Kap De Alvis, PNG Rodrigo
Read the Full Article on Uva Clinical Anaesthesia and Intensive Care

Other posts featuring Indunil Karunarathna on Hemostasis Today.
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC